Filter News
Area of Research
- Advanced Manufacturing (4)
- Biology and Environment (8)
- Clean Energy (57)
- Computational Biology (1)
- Computer Science (2)
- Electricity and Smart Grid (3)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (28)
- Fusion Energy (10)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials (57)
- Materials for Computing (5)
- National Security (15)
- Neutron Science (101)
- Nuclear Science and Technology (39)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (40)
News Topics
- (-) Grid (62)
- (-) Neutron Science (131)
- (-) Nuclear Energy (108)
- (-) Quantum Computing (34)
- 3-D Printing/Advanced Manufacturing (121)
- Advanced Reactors (34)
- Artificial Intelligence (91)
- Big Data (53)
- Bioenergy (91)
- Biology (98)
- Biomedical (58)
- Biotechnology (22)
- Buildings (57)
- Chemical Sciences (63)
- Clean Water (29)
- Climate Change (99)
- Composites (26)
- Computer Science (187)
- Coronavirus (46)
- Critical Materials (26)
- Cybersecurity (35)
- Decarbonization (79)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (108)
- Environment (194)
- Exascale Computing (37)
- Fossil Energy (5)
- Frontier (42)
- Fusion (54)
- High-Performance Computing (84)
- Hydropower (11)
- Irradiation (3)
- Isotopes (53)
- ITER (7)
- Machine Learning (47)
- Materials (144)
- Materials Science (140)
- Mathematics (7)
- Mercury (12)
- Microelectronics (3)
- Microscopy (51)
- Molten Salt (8)
- Nanotechnology (60)
- National Security (61)
- Net Zero (13)
- Partnerships (44)
- Physics (61)
- Polymers (33)
- Quantum Science (69)
- Renewable Energy (2)
- Security (24)
- Simulation (47)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Summit (57)
- Sustainable Energy (125)
- Transformational Challenge Reactor (7)
- Transportation (97)
Media Contacts
The Spallation Neutron Source — already the world’s most powerful accelerator-based neutron source — will be on a planned hiatus through June 2024 as crews work to upgrade the facility. Much of the work — part of the facility’s Proton Power Upgrade project — will involve building a connector between the accelerator and the planned Second Target Station.
In June, ORNL hit a milestone not seen in more than three decades: producing a production-quality amount of plutonium-238
The Exascale Small Modular Reactor effort, or ExaSMR, is a software stack developed over seven years under the Department of Energy’s Exascale Computing Project to produce the highest-resolution simulations of nuclear reactor systems to date. Now, ExaSMR has been nominated for a 2023 Gordon Bell Prize by the Association for Computing Machinery and is one of six finalists for the annual award, which honors outstanding achievements in high-performance computing from a variety of scientific domains.
Cadet Elyse Wages, a rising junior at the United States Air Force Academy, visited ORNL with one goal in mind: collect air.
Neutron experiments can take days to complete, requiring researchers to work long shifts to monitor progress and make necessary adjustments. But thanks to advances in artificial intelligence and machine learning, experiments can now be done remotely and in half the time.
Rose Montgomery, a distinguished researcher and leader of the Used Fuel and Nuclear Material Disposition group at ORNL, has been selected to participate in the U.S. WIN Nuclear Executives of Tomorrow, or NEXT, class of 2023 to 2024.
Technologies developed by researchers at ORNL have received six 2023 R&D 100 Awards.
Researchers at the Department of Energy’s Oak Ridge National Laboratory are leading the way in understanding the effects of electrical faults in the modern U.S. power grid.
A group at the Department of Energy's Oak Ridge National Laboratory made a difference for local youth through hands-on projects that connected neutron science and engineering intuitively.
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.